» Articles » PMID: 20538721

Protein Phosphatase 2Cbetal Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells

Overview
Specialty Pharmacology
Date 2010 Jun 12
PMID 20538721
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The human pregnane X receptor (hPXR) regulates the expression of CYP3A4, which plays a vital role in hepatic drug metabolism and has considerably reduced expression levels in proliferating hepatocytes. We have recently shown that cyclin-dependent kinase 2 (CDK2) negatively regulates hPXR-mediated CYP3A4 gene expression. CDK2 can be dephosphorylated and inactivated by protein phosphatase type 2C beta isoform long (PP2Cbetal), a unique phosphatase that was originally cloned from human liver. In this study, we sought to determine whether PP2Cbetal is involved in regulating hPXR's transactivation activity and whether PP2Cbetal affects CDK2 regulation of this activity in HepG2 liver carcinoma cells. In transactivation assays, transiently coexpressed PP2Cbetal significantly enhanced the hPXR-mediated CYP3A4 promoter activity and decreased the inhibitory effect of CDK2 on hPXR transactivation activity. In addition, shRNA-mediated down-regulation of endogenous PP2Cbetal promoted cell proliferation, inhibited the interaction of hPXR with steroid receptor coactivator-1, and attenuated the hPXR transcriptional activity. The levels of PP2Cbetal did not affect hPXR expression. Our results show for the first time that PP2Cbetal is essential for hPXR activity and can positively regulate this activity by counteracting the inhibitory effect of CDK2. Our results implicate a novel and important role for PP2Cbetal in regulating hPXR activity and CYP3A4 expression by inhibiting or desensitizing signaling pathways that negatively regulate the function of pregnane X receptor in liver cells and are consistent with the notion that both the activity of hPXR and the expression of CYP3A4 are regulated in a cell cycle-dependent and cell proliferation-dependent manner.

Citing Articles

Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis.

Qin M, Xin Y, Bian Y, Yang X, Xi T, Xiong J Cells. 2022; 11(2).

PMID: 35053380 PMC: 8773821. DOI: 10.3390/cells11020264.


Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.

Oladimeji P, Cui H, Zhang C, Chen T Expert Opin Drug Metab Toxicol. 2016; 12(9):997-1010.

PMID: 27295009 PMC: 4992434. DOI: 10.1080/17425255.2016.1201069.


Mg2+/Mn2+-dependent phosphatase 1A is involved in regulating pregnane X receptor-mediated cytochrome p450 3A4 gene expression.

Pondugula S, Flannery P, Apte U, Babu J, Geetha T, Rege S Drug Metab Dispos. 2015; 43(3):385-91.

PMID: 25561723 PMC: 11024896. DOI: 10.1124/dmd.114.062083.


Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR.

Pondugula S, Flannery P, Abbott K, Coleman E, Mani S, Samuel T Toxicol Lett. 2014; 232(3):580-9.

PMID: 25542144 PMC: 4568078. DOI: 10.1016/j.toxlet.2014.12.015.


IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.

Karthikeyan C, Lee C, Moore J, Mittal R, Suswam E, Abbott K Bioorg Med Chem. 2014; 23(3):602-11.

PMID: 25537531 PMC: 4301998. DOI: 10.1016/j.bmc.2014.11.043.


References
1.
Bettoun D, Buck 2nd D, Lu J, Khalifa B, Chin W, Nagpal S . A vitamin D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand. J Biol Chem. 2002; 277(28):24847-50. DOI: 10.1074/jbc.C200187200. View

2.
Zeng F, Cui J, Liu L, Chen T . PAX3-FKHR sensitizes human alveolar rhabdomyosarcoma cells to camptothecin-mediated growth inhibition and apoptosis. Cancer Lett. 2009; 284(2):157-64. PMC: 2739888. DOI: 10.1016/j.canlet.2009.04.016. View

3.
Lichti-Kaiser K, Xu C, Staudinger J . Cyclic AMP-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner. J Biol Chem. 2009; 284(11):6639-49. PMC: 2652295. DOI: 10.1074/jbc.M807426200. View

4.
Zhou S . Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab. 2008; 9(4):310-22. DOI: 10.2174/138920008784220664. View

5.
Harmsen S, Meijerman I, Beijnen J, Schellens J . The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology. Cancer Treat Rev. 2007; 33(4):369-80. DOI: 10.1016/j.ctrv.2007.02.003. View